Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Change in Cash (2013 - 2026)

Scynexis' (SCYX) quarterly Change in Cash came in at -$26.2 million in Q2 2026, down 793.07% on a YoY basis from $3.8 million in Q2 2025, and down 269.89% quarter-over-quarter from $15.4 million in Q1 2026.

Analysis

Scynexis (SCYX) Change in Cash (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Change in Cash for 14 consecutive years, with -$26.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Cash fell 793.07% year-over-year to -$26.2 million; the trailing twelve-month figure through Jun 2026 stood at -$588000.0 (up 96.15% YoY), and the FY2025 full-year result was $4.9 million, up 126.96% from the prior year.
  • Change in Cash declined to -$26.2 million in Q2 2026 per SCYX's latest filing, from $15.4 million in the prior quarter.
  • Across five years, Change in Cash topped out at $31.4 million in Q2 2023 and bottomed at -$50.1 million in Q3 2022.
  • Historically, Change in Cash has averaged -$5.2 million across 5 years, with a median of -$9.2 million in 2022.
  • The sharpest annual moves came in 2022 and 2026: Change in Cash slumped 800.39% in 2022, then surged 269.2% in 2026.
  • Over 5 years, Change in Cash stood at -$22.8 million in 2022, then soared by 56.06% to -$10.0 million in 2023, then slipped by 26.51% to -$12.7 million in 2024, then surged by 150.97% to $6.5 million in 2025, then sank by 505.2% to -$26.2 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered -$26.2 million, $15.4 million, and $6.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -4.45 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 649.20 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -504.60 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -185.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -2.94 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -170.44 Mn
10 Scynexis 58.41 Mn -56.29 Mn - -26.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -26.18 Mn
Mar 31, 2026 15.41 Mn
Dec 31, 2025 6.46 Mn
Sep 30, 2025 3.72 Mn
Jun 30, 2025 3.78 Mn
Mar 31, 2025 -9.11 Mn
Dec 31, 2024 -12.68 Mn
Sep 30, 2024 2.74 Mn
Jun 30, 2024 -9.49 Mn
Mar 31, 2024 1.43 Mn
Dec 31, 2023 -10.02 Mn
Sep 30, 2023 -13.89 Mn
Jun 30, 2023 31.37 Mn
Mar 31, 2023 -18.90 Mn
Dec 31, 2022 -22.81 Mn
Sep 30, 2022 -50.07 Mn
Jun 30, 2022 23.48 Mn
Mar 31, 2022 -9.27 Mn
Dec 31, 2021 4.38 Mn
Sep 30, 2021 -12.39 Mn